Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exogenus Therapeutics

Exogenus Therapeutics
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$55.8K LATEST DEAL AMOUNT
4 INVESTORS
Description

Operator of a biotechnology company. The company's Exo-Wound is used as a treatment tool for wound healing, enabling people to get treatment for skin lesions.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Biocant Park Center 04
  • Lote 2
  • Cantanhede, 3060-197
  • Portugal

+351 231 000 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Exogenus Therapeutics’s full profile, request a free trial.

Exogenus Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 17-Oct-2016 $55.8K 00000 Completed Startup
4. Seed Round 10-Dec-2015 00000 00000 Completed Startup
3. Grant 000.00 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2015 $123K $123K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Exogenus Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Horizon 2020 Government 000 0000 000000 0
Acelerador de ComercializaĆ§Ć£o de Tecnologias Accelerator/Incubator 000 0000 000000 0
Caixa Capital Venture Capital Minority 000 0000 000000 0
Biocant Park Accelerator/Incubator Minority 000 0000 000000 0

Exogenus Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Luisa Marques Co Founder & Chief Operating Officer
Joana Correia Ph.D Co-Founder, Chief Scientific Officer & Executive Director

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »